UBS Group Begins Coverage on Insulet (NASDAQ:PODD) : vimarsa

Research analysts at UBS Group began coverage on shares of Insulet (NASDAQ:PODD – Get Rating) in a note issued to investors on Tuesday, The Fly reports. The firm set a “neutral” rating on the medical instruments supplier’s stock. Other equities analysts also recently issued research reports about the company. Morgan Stanley increased their price target […]

Related Keywords

Kentucky , United States , Charles Alpuche , Raymond James , Shacey Petrovic , Mission Capital , Nasdaq , Regal Investment Advisors , B Riley Wealth Advisors Inc , Citigroup , Morgan Stanley , Insulet Company Profile , Barclays , Insulet Corp , Get Rating , Stock Down , Director Shacey Petrovic , Riley Wealth Advisors , Investment Advisors , Teachers Retirement System , Retirement System , Omnipod System , Insulet Daily , Insulet , Nasdaq Podd , Podd , Medical , 45784p10 , Initiated Coverage , Ubs Group Ag ,